Table 1 Patients’ characteristics and clinical results
Age (years) | T-stage | Gleason-score | PSA pre-RT(ng/ml) | NCCN-risk-category | Max. GI-toxicity | Max. GU-toxicity | |
|---|---|---|---|---|---|---|---|
Pat 1 | 67 | 1c | 3+3 | 7.6 | low | 1 | 1 |
Pat 2 | 67 | 1c | 3+4 | 9.9 | intermediate | 1 | 1 |
Pat 3 | 76 | 2b | 3+4 | 4.4 | intermediate | 1 | 1 |
Pat 4 | 60 | 1c | 3+4 | 5.8 | intermediate | 1 | 2 |
Pat 5 | 67 | 1c | 3+4 | 5.1 | intermediate | 1 | 1 |
Pat 6 | 79 | 2a | 4+3 | 9.9 | intermediate | 1 | 2 |
Pat 7 | 78 | 1c | 3+4 | 13 | intermediate | 0 | 2 |
Pat 8 | 76 | 1c | 4+3 | 9.2 | intermediate | 0 | 2 |
Pat 9 | 75 | 1c | 4+3 | 3.9 | intermediate | 0 | 1 |
Pat 10 | 66 | 1c | 3+3 | 8.5 | low | 1 | 2 |